DePuy Synthes Spine and DePuy Synthes Biomaterials have gained the exclusive worldwide rights to market LifeNet Health's cellular allograft product. This agreement is DePuy Synthes Spine's first move into cellular allografts for spinal fusion.
LifeNet Health is a developer of allograft bioimplants and cellular therapies.
More Articles on Devices:
Texas Hospital Purchases Second Renaissance Spine System From Mazor Robotics
Smith & Nephew to Purchase ArthroCare for $1.7B
Global Medical Device Market to Reach $434.4B by 2017